These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 1776855

  • 21. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A, Strobl L, Feederle R, Schweizer M, Koch E, Eick D, Wiegand H, Bornkamm GW.
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [Abstract] [Full Text] [Related]

  • 22. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin.
    Zhu Q, Center MS.
    Cancer Res; 1994 Aug 15; 54(16):4488-92. PubMed ID: 8044800
    [Abstract] [Full Text] [Related]

  • 23. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T, Kohno K, Kuwano M, Gopas J, Kung HF, Ono M.
    Oncogene; 1996 Apr 18; 12(8):1625-33. PubMed ID: 8622882
    [Abstract] [Full Text] [Related]

  • 24. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
    Eick D, Polack A, Kofler E, Lenoir GM, Rickinson AB, Bornkamm GW.
    Oncogene; 1990 Sep 18; 5(9):1397-402. PubMed ID: 2216463
    [Abstract] [Full Text] [Related]

  • 25. Functional domains of c-Myc involved in the commitment and differentiation of murine erythroleukemia cells.
    Ohmori Y, Tanabe J, Takada S, Lee WM, Obinata M.
    Oncogene; 1993 Feb 18; 8(2):379-86. PubMed ID: 8426744
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Immortalization by truncated myc or ras genes and synergism between myc and ras genes in cell transformation.
    Spandidos DA, Lang JC.
    Anticancer Res; 1989 Feb 18; 9(4):1149-52. PubMed ID: 2683993
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.
    Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.
    Mautner J, Behrends U, Hörtnagel K, Brielmeier M, Hammerschmidt W, Strobl L, Bornkamm GW, Polack A.
    Oncogene; 1996 Mar 21; 12(6):1299-307. PubMed ID: 8649832
    [Abstract] [Full Text] [Related]

  • 33. MAZ, a Myc-associated zinc finger protein, is essential for the ME1a1-mediated expression of the c-myc gene during neuroectodermal differentiation of P19 cells.
    Komatsu M, Li HO, Tsutsui H, Itakura K, Matsumura M, Yokoyama KK.
    Oncogene; 1997 Sep 04; 15(10):1123-31. PubMed ID: 9294605
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of murine erythroleukemia cell differentiation by normal and partially deleted c-myc genes.
    Bar-Ner M, Messing LT, Segal S.
    Immunobiology; 1992 Aug 04; 185(2-4):150-8. PubMed ID: 1452198
    [Abstract] [Full Text] [Related]

  • 35. [Structure of the s-myc gene involved in tumor suppression].
    Kuchino Y.
    Nihon Rinsho; 1990 Aug 04; 48(8):227-35. PubMed ID: 2255087
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lack of inhibition of glutathione reductase by anthracycline antibiotics.
    Dershwitz M, Novak RF.
    Biochem Pharmacol; 1981 Mar 15; 30(6):676-8. PubMed ID: 7271908
    [No Abstract] [Full Text] [Related]

  • 40. Evaluation of the epidoxorubicin--formaldehyde conjugate, epidoxoform, in a mouse mammary carcinoma model.
    Dernell WS, Powers BE, Taatjes DJ, Cogan P, Gaudiano G, Koch TH.
    Cancer Invest; 2002 Mar 15; 20(5-6):713-24. PubMed ID: 12197227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.